The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IMW 2019 | NGS or flow-based MRD in myeloma? A need for consistency
Bruno Paiva
• 12 Sep 2019
Bruno Paiva, PhD, from the University of Navarra Clinic, Pamplona, Spain, discusses NGS and flow-based MRD detection, highlighting the more important point of consistency rather than the debate of which modality is better. Recorded at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.
